newsfilter
← Latest News
GlobeNewswire·

Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial

TORONTO, March 16, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company") (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization